Tse Ping
board of director
cardiology
Lifebond
Israel
Biography
Mr. Tse Ping is the founder and chairman of Sino Biopharmaceutical Limited, which recorded 12.38 Billion HKD in revenue and 2.36 Billion HKD in net profits in 2014. Sino Pharmaceuticals, which has the largest market cap of any company in the healthcare sector on the Hong Kong Exchange, spent about 10% of its sales revenue in 2014 on research and development. Mr. Ping is also the vice chairman of the Charoen Pokphand Group (“CP Group”), the largest company in Thailand. The company has an annual revenue of more than 75 Billion RMB, operates more than 300 factories and subsidiaries in China, which employ more than 80,000 people. CP Group invests more than 110 Billion RMB annually. Mr. Tse Ping was a member of the Ninth, Tenth and Eleventh National Committee of the Chinese People’s Political Consultative Conference. He holds an honorable doctorate from the University of West Alabama.
Research Interest
pharmaceutical industry.
